Bio2Skin a novel biomaterial for medical skin adhesives
Bio2Skin is a revolutionary new generation of medical-grade adhesives with a wide range of uses in the application of medical devices and wound dressings. This disruptive and unique adhesive will provide a welcome alternative to t...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto Bio2Skin
Duración del proyecto: 6 meses
Fecha Inicio: 2019-07-24
Fecha Fin: 2020-01-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Bio2Skin is a revolutionary new generation of medical-grade adhesives with a wide range of uses in the application of medical devices and wound dressings. This disruptive and unique adhesive will provide a welcome alternative to the current glues used in the application of devices and dressings to the skin which tend to provoke severe skin problems.
Currently available adhesives are viscous materials made of synthetic chemicals that fill the skin irregularities, to augment the contact area. When peeled off, they provoke dermatitis, which is caused by the removal of a large amount of epidermis cells. Bio2Skin allows the development of a line of products that can provide effective protection against Medical Adhesive-Related Skin Injury (MARSI).
Bio2Skin is based on our unique research on glue-less naturally occurring chemicals results in adhesion to surfaces materially different. Our novel material results from the combination of highly biocompatible chemically-modified polymers that display excellent adhesion properties equivalent or better to current chemical glue-based adhesives.
As our product is based with nature in mind, Bio2Skin binds to the natural features of skin offering good adhesion properties without damaging the skin either during use or upon removal, reducing or even eliminating the skin damage caused by the continuous use of current adhesives.
Small-scale pre-clinical tests at the Centre for Nanotechnology and Smart Materials (CeNTI Portugal) so far have been extremely promising, and we believe we can make a significant impact in the medical adhesive market which is projected to reach €10 billion by 2019.